Cargando…

Prophylactic anticoagulation for patients in hospital with covid-19

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2021
Materias:	Corrections
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906110/ https://www.ncbi.nlm.nih.gov/pubmed/33632782 http://dx.doi.org/10.1136/bmj.n538

Ejemplares similares

Venous Thromboembolism in Hospitalized Patients With COVID-19 Receiving Prophylactic Anticoagulation
por: Boonyasai, Romsai T., et al.
Publicado: (2020)

Personalized prophylactic anticoagulation in hospitalized patients with Covid-19 – The role of anti-Xa monitoring
por: Kofteridis, Diamantis P., et al.
Publicado: (2021)

Intracranial hemorrhage complicating anticoagulant prophylactic therapy in three hospitalized COVID-19 patients
por: Ghani, Muhammad Usman, et al.
Publicado: (2020)

Prevalence of thromboembolic events and status of prophylactic anticoagulant therapy in hospitalized patients with COVID-19 in Japan
por: Fujiwara, Sho, et al.
Publicado: (2021)

EVALUATION OF THERAPEUTIC VS PROPHYLACTIC ANTICOAGULATION IN NONCRITICALLY ILL PATIENTS HOSPITALIZED WITH COVID-19 PNEUMONIA
por: GHOSH, KULDEEP, et al.
Publicado: (2022)

Prophylactic versus therapeutic anticoagulation for survival of patients with COVID-19 on steroid
por: Kuno, Toshiki, et al.
Publicado: (2021)

The impact of different prophylactic anticoagulation doses on the outcomes of patients with COVID-19
por: Jiménez-Soto, Rodolfo, et al.
Publicado: (2021)

The Impact of Different Prophylactic Anticoagulation Doses on the Outcomes of Patients with COVID-19
por: Jiménez-Soto, Rodolfo, et al.
Publicado: (2020)

COVID-19-Associated Coagulopathy: Safety and Efficacy of Prophylactic Anticoagulation Therapy in Hospitalized Adults with COVID-19
por: Chambers, Isaac, et al.
Publicado: (2020)

Prothrombotic Milieu, Thrombotic Events and Prophylactic Anticoagulation in Hospitalized COVID-19 Positive Patients: A Review
por: Cryer, Michael Joseph, et al.
Publicado: (2022)

High-Dose Prophylactic Anticoagulation in Severe COVID-19 Pneumonia
por: Nadeem, Rashid, et al.
Publicado: (2021)

Effect of combination of prophylactic or therapeutic anticoagulation with aspirin on the outcomes of hospitalized COVID-19 patients: An observational retrospective study
por: Mina, Jonathan, et al.
Publicado: (2023)

Prophylactic Anticoagulation in Nephrotic Syndrome
por: Gerstein, Jonathon, et al.
Publicado: (2023)

Fatal retroperitoneal hematoma associated with Covid-19 prophylactic anticoagulation protocol
por: Teta, Michael, et al.
Publicado: (2021)

Impact of High-Dose Prophylactic Anticoagulation in Critically Ill Patients With COVID-19 Pneumonia
por: Tacquard, Charles, et al.
Publicado: (2021)

Apixaban Prophylactic Anticoagulation in Patients with Nephrotic Syndrome
por: Van Meerhaeghe, Tess, et al.
Publicado: (2022)

Intermediate-to-therapeutic versus prophylactic anticoagulation for coagulopathy in hospitalized COVID-19 patients: a systemic review and meta-analysis
por: Zhang, Sirui, et al.
Publicado: (2021)

Prophylactic Anticoagulant Treatment Might Have an Anti-inflammatory Effect and Reduce Mortality Rates in Hospitalized COVID-19 Patients?
por: Alkan, Sevil, et al.
Publicado: (2022)

The Comparison of Therapeutic With Prophylactic Anticoagulation on Mortality, Risk of Bleeding, and Thromboembolism in Hospitalized Patients With COVID-19: A Systematic Review
por: Kham, Nang I, et al.
Publicado: (2022)

Safety and efficacy of prophylactic anticoagulation versus therapeutic anticoagulation in hospital‐admitted COVID‐19 patients: A systematic review and meta‐analysis of randomized controlled trials
por: Rauniyar, Robin, et al.
Publicado: (2022)

A Case of Iliopsoas Hematoma Caused by Prophylactic Anticoagulation against COVID-19
por: Masaki, Shoichi, et al.
Publicado: (2022)

Aspirin Therapy on Prophylactic Anticoagulation for Patients Hospitalized With COVID‐19: A Propensity Score‐Matched Cohort Analysis of the HOPE‐COVID‐19 Registry
por: Santoro, Francesco, et al.
Publicado: (2022)

Adoption of a National Prophylactic Anticoagulation Guideline for Hospitalized Pregnant Women With COVID-19: Retrospective Cohort Study
por: Hwang, Yeon-Mi, et al.
Publicado: (2023)

Prophylactic anticoagulant therapy for reducing the risk of stroke and other thrombotic events in COVID-19 patients
por: Aghamohammadi, Mehdi, et al.
Publicado: (2020)

Early initiation of prophylactic anticoagulation for prevention of COVID-19 mortality: a nationwide cohort study of hospitalized patients in the United States
por: Rentsch, Christopher T, et al.
Publicado: (2020)

Risk Factors of Venous Thromboembolism in Noncritically Ill Patients Hospitalized for Acute COVID-19 Pneumonia Receiving Prophylactic-Dose Anticoagulation
por: Poletto, Francesco, et al.
Publicado: (2022)

A Case of COVID-19 Complicated by Venous Thromboembolism Despite Being on Prophylactic Anticoagulation
por: Rout, Amit, et al.
Publicado: (2020)

Full versus prophylactic-intermediate doses of anticoagulants in COVID-19: a meta-analysis
por: Loffredo, Lorenzo, et al.
Publicado: (2022)

High-Dose Prophylactic Anticoagulation for COVID-19 Pneumonia: A Review of Benefits and Risks
por: Kattakola, Yeshu, et al.
Publicado: (2023)

Anticoagulation in hospitalized patients with COVID-19
por: Baumann Kreuziger, Lisa, et al.
Publicado: (2022)

Correction: Thrombotic and bleeding events, mortality, and anticoagulant use among 546,656 hospitalized patients with COVID‑19 in the United States: a retrospective cohort study
por: Deitelzweig, Steve, et al.
Publicado: (2022)

Prophylactic versus therapeutic dose anticoagulation effects on survival among critically ill patients with COVID-19
por: Hoogenboom, Wouter S., et al.
Publicado: (2022)

Treatment with prophylactic oral anticoagulants and the risk of mortality in COVID-19 patients: a nationwide cohort study
por: Altaraihi, Sarah, et al.
Publicado: (2023)

Correction to: In silico investigation of the therapeutic and prophylactic potential of medicinal substances bearing guanidine moieties against COVID-19
por: Esam, Zohreh, et al.
Publicado: (2023)

TRENDS AND FACTORS ASSOCIATED WITH PROPHYLACTIC ANTICOAGULATION STRATEGIES IN COVID-19: AN ANALYSIS OF THE AHA COVID-19 CVD REGISTRY
por: Lopes, Mathew, et al.
Publicado: (2023)

Thrombotic Events in COVID-19 Are Associated With a Lower Use of Prophylactic Anticoagulation Before Hospitalization and Followed by Decreases in Platelet Reactivity
por: Clark, Chantal C., et al.
Publicado: (2021)

Prophylactic anticoagulation with low molecular weight heparin in COVID-19: cohort studies in Denmark and Sweden
por: Lund, Lars Christian, et al.
Publicado: (2022)

Correction: Role of combining anticoagulant and antiplatelet agents in COVID-19 treatment: a rapid review
Publicado: (2021)

POS-956 ACUTE HEMATOMA ASSOCIATED WITH PROPHYLACTIC ANTICOAGULATION IN DIALYSIS PATIENTS WITH COVID 19: TWO CASE REPORTS
por: Hafi, K., et al.
Publicado: (2022)

Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications
por: Kelddal, Sarah, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2c0i3qipl0r2ogueh56g8h2o4a